SCHEMBL18274471

SCHEMBL18274471

Cc1cnc(C(C#N)N2CCOCC2)cn1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.48
▸ SMN1; SMN2 Q16637 4/20 0.47
▸ ACHE P22303 2/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ HPGD P15428 2/20 0.35
▸ KHK P50053 1/20 0.35
▸ MAPT P10636 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ CYP1A2 P05177 1/20 0.31
▸ CASP1 P29466 1/20 0.31
▸ CASP7 P55210 1/20 0.31
▸ IDH1 O75874 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18274508 0.84 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2ACHEKDM4EHSD17B10
SCHEMBL18274496 0.82 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2ACHEL3MBTL1MEN1
SCHEMBL12701471 0.77 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2ACHEL3MBTL1MEN1
SCHEMBL18274483 0.77 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2ACHEL3MBTL1MEN1
SCHEMBL16995086 0.74 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2ACHEL3MBTL1MEN1
SCHEMBL10749589 0.73 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2ACHEL3MBTL1MEN1
SCHEMBL15797371 0.73 DPP4 (0.46) ALDH1A1SMN1; SMN2KDM4EHSD17B10MAPT
SCHEMBL18274461 0.72 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2ACHEL3MBTL1MEN1
SCHEMBL16995108 0.72 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2ACHEL3MBTL1MEN1
SCHEMBL12701343 0.72 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2ACHEL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2931717-B1 INDOLE CARBOXAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2016-12-07 — — EP disclosed
Send feedback